Timothy Cook, MD
Pulmonary Disease · Sherwood, ARNPI 1659342038
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 53.7% of the total. 2025 is the largest year on record at $908, more than ten times the $11 reported in 2019. That places this record below the midpoint for pulmonary disease clinicians in AR, where the typical reported total is $3,332.
Across 35 payments — averaging $54.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- Jazz Pharmaceuticals Inc.$417
- Harmony Biosciences LLC$158
- Resmed Corp$92
- 3b Medical, Inc.$76
- Axsome Therapeutics, Inc.$60
- plus $82 from 5 others
Across 35 payments — averaging $18,186 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$637K
What the payments were for
- Travel & lodging$86846%
- Food & beverage$1,04054%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 2 | $1,024 |
| Jazz Pharmaceuticals Inc. | 13 | $417 |
| Harmony Biosciences LLC | 10 | $158 |
| Resmed Corp | 1 | $92 |
| 3b Medical, Inc. | 1 | $76 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Lilly USA, LLC | 1 | $20 |
| GSK | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$868
- Inspire Upper Airway Stimulation System$155
- XYWAV$125
- SUNOSI$112
How this compares
$1,908 in reported general payments places this provider in the 30th percentile of 102 pulmonary disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $5,783 |
| Montelukast Sodium | 27 | $278 |
| Zolpidem Tartrate | 43 | $51 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Sherwood
- Lee KendrickSherwood$4K
- Ladly AbrahamConway$371K
- Daniel PaulRogers$244K
- Jason McKinneyRogers$86K
- Arturo MeadeFort Smith$67K
- Nikhil MeenaLittle Rock$63K
- Penchala MittadodlaRogers$21K
- Mark SiffordJonesboro$20K
- Zafirah SalmanNorth Little Rock$18K
- Dominika SzwedoNorth Little Rock$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.